Global Cord Blood Corporation (CORBF) Stock

About Global Cord Blood Corporation

Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Global Cord Blood Corporation is headquartered in HK.

Global Cord Blood Corporation (CORBF) stock trades at $0.95 with a market capitalization of $127.22M. The stock is valued at a price-to-earnings (P/E) ratio of 1.56, price-to-book of 0.16, price-to-sales of 0.69. Over the past 52 weeks the stock has ranged between $0.20 and $1.75, and currently trades 45.7% below its 52-week high.

On profitability, Global Cord Blood Corporation generates a return on equity (ROE) of 10.82%, return on capital employed of 7.72%, an operating margin of 48.97%, a net profit margin of 40.30%.

Official website: www.globalcordbloodcorporation.com